Libri sul tema "Leukemia Chemotherapy"

Segui questo link per vedere altri tipi di pubblicazioni sul tema: Leukemia Chemotherapy.

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-50 libri per l'attività di ricerca sul tema "Leukemia Chemotherapy".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi i libri di molte aree scientifiche e compila una bibliografia corretta.

1

Ueda, Takanori, a cura di. Chemotherapy for Leukemia. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-3332-2.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
2

Schmidt, Carolina Witchmichen Penteado, e Kaléu Mormino Otoni, a cura di. Chemotherapy and Pharmacology for Leukemia in Pregnancy. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-54058-6.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
3

Heinemann, Volker. Supportive therapy in leukemia patients: Clinical handbook with checklist. Stuttgart ; New York: G. Thieme Verlag ; New York : Thieme Medical Publishers, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
4

Ludwig, Deborah. Rebirth: A leukemia survivor's journal of healing during chemotherapy, bone marrow transplant and recovery. [Place of publication not identified]: Xlibris Corp., 2009.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
5

1946-, Cheson Bruce D., Keating Michael J. 1943- e Plunkett William 1943-, a cura di. Nucleoside analogs in cancer therapy. New York: M. Dekker, 1997.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
6

1951-, Pui Ching-Hon, a cura di. Treatment of acute leukemias: New directions for clinical research. Totowa, N.J: Humana Press, 2003.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
7

Hancock, Sarah. Fludarabine as first line therapy for chronic lymphocytic leukaemia. Birmingham: University of Birmingham, Department of Public Health and Epidemiology, 2003.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
8

Kaspers, G. J. L., 1963-, Pieters R e International Symposium on Drug Resistance in Leukemia and Lymphoma (3rd : 1998 : Amsterdam, Netherlands), a cura di. Drug resistance in leukemia and lymphoma III. New York: Kluwer Academic/Plenum Press, 1999.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
9

Heim, Marcel U. The leukemia patient as a partner in therapy: A guidebook for patients, relatives, nurses, and physicians. Stuttgart: GTV Stuttgart, 1994.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
10

Kaspers, G. J. L., 1963-, a cura di. Drug resistance in leukemia and lymphoma: The clinical value of laboratory studies. Chur, Switzerland: Harwood Academic Publishers, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
11

W, Hiddemann, a cura di. Acute leukemias: Pharmacokinetics and management of relapsed and refractory disease. Berlin: Springer-Verlag, 1992.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
12

Polliack, Aaron. A handbook of essential drugs and regimens in hematological oncology. Chur: Harwood Academic Publishers, 1991.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
13

Legendre, Ginette. L'histoire de Casse-Tête: La pouliche leucémique. Moncton, N.-B: Éditions de la Francophonie, 2006.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
14

Lyman, Gary H. Chemotherapy for Chronic Lymphocytic Leukemia. Oxford University Press, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
15

Bennett, Lunawati L. Frontiers in Leukemia Pharmacotherapy. Nova Science Publishers, Incorporated, 2019.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
16

Ueda, Takanori. Chemotherapy for Leukemia: Novel Drugs and Treatment. Springer, 2018.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
17

Ueda, Takanori. Chemotherapy for Leukemia: Novel Drugs and Treatment. Springer, 2017.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
18

Ueda, Takanori. Chemotherapy for Leukemia: Novel Drugs and Treatment. Springer, 2017.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
19

Bryson, James Scott. Characteristics of reovirus-mediated chemoimmunotherapy of murine L1210 leukemia. 1985.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
20

Farone, Anthony Louis. Interleukin-2 chemoimmunotherapy of murine L1210 leukemia. 1988.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
21

Farone, Anthony Louis. Interleukin-2 chemoimmunotherapy of murine L1210 leukemia. 1988.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
22

Koenigsberg, Adam David. Alpha/Beta and Gamma interferon responses during reovirus-mediated chemoimmunotherapy of L1210 leukemia. 1988.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
23

Heinemann, Volker, e Ulrich Jehn. Supportive Therapy in Leukemia Patients (Supportive Measures in Oncology). Thieme Publishing Group, 1992.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
24

Kaspers, G. J. L., 1963-, Pieters R e Veerman A. J. P, a cura di. Drug resistance in leukemia and lymphoma II. Amsterdam, the Netherlands: Harwood Academic Publishers, 1997.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
25

Gill, Harinder, Yok Lam Kwong e Farhad Ravandi, a cura di. Acute Promyelocytic Leukemia - Towards a Chemotherapy-Free Approach to Cure in All Patients. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-475-6.

Testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
26

Schmidt, Carolina Witchmichen Penteado, e Kaléu Mormino Otoni. Chemotherapy and Pharmacology for Leukemia in Pregnancy: Guidelines and Strategies for Best Practices. Springer International Publishing AG, 2020.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
27

Supportive Measures of Oncology. Thieme-Stratton Corp, 1998.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
28

Farone, Anthony L. Characterization of the immune responses during chemoimmunotherapy of murine L1210 leukemia. 1992.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
29

Roman, Eve, Alexandra Smith e Lorelei Mucci. Leukemias. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190676827.003.0028.

Testo completo
Abstract (sommario):
Leukemias are a diverse group of acute and chronic haematological malignancies, that account for 2% to 3% of cancers globally. Recent advances in molecular biology and therapy have transformed the landscape for several leukemia subtypes changing some, but by no means all, from rapidly fatal diseases to treatable conditions with a good prognosis. In general, however, this progress has not been matched by new aetiological insights. Albeit accounting for a relatively small proportion, genetic predisposition syndromes such as neurofibromatosis, Li-Fraumeni and Trisomy 21, have the biggest impact in children and young adults. At older ages, established chemical, physical and biological risk factors, which explain only a small proportion of the total disease burden, include chemotherapy for a preceding cancer, ionizing radiation, and the viral infections human T-cell lymphotropic virus type 1 (HTLV-1) which causes the rare adult T-cell leukemia/lymphoma (ATLL) and the human immunodeficiency virus (HIV) which is associated with an increased risk of acute lymphoid leukaemias. Workplace exposures to potential carcinogens such as benzene, butadiene, and styrene have also been linked to increased risk of leukemia.
Gli stili APA, Harvard, Vancouver, ISO e altri
30

National Institute for Clinical Excellence. Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia. London, 2001.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
31

Haas, David Gerard. Cytotoxic T lymphocyte and natural killer cell responses following chemoimmunotherapy of murine L1210 leukemia. 1986.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
32

Ritter, Jörg, Ursula Creutzig e Günther Schellong. Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies. Springer, 2011.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
33

Ritter, Jörg, Ursula Creutzig e Günther Schellong. Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies. Springer London, Limited, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
34

Creutzig, U., e J. Ritter. Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies. Springer, 1990.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
35

1946-, Creutzig U., Ritter Jörg e Schellong Günther, a cura di. Acute myelogenous leukemia in childhood: Implications of therapy studies for future risk-adapted treatment strategies. Berlin: Springer-Verlag, 1990.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
36

Linet, Martha S., Lindsay M. Morton, Susan S. Devesa e Graça M. Dores. Leukemias. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0038.

Testo completo
Abstract (sommario):
The 2001 World Health Organization (WHO) classification of hematopoietic and lymphoid neoplasms categorized “the leukemias” into two major groupings—myeloid and lymphoid. Myeloid neoplasms, which are the primary focus of this chapter, include acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN). Lymphoid neoplasms are mostly reviewed as part of non-Hodgkin lymphoma in Chapter 40 of this volume, although descriptive patterns and selected etiologic studies are briefly discussed in this chapter because of historical trends. Worldwide, leukemias are ranked eleventh among all cancer types, comprising approximately 2.5% of all malignancies. Exposure to ionizing radiation and certain chemical carcinogens (e.g., cytotoxic chemotherapy, benzene, formaldehyde) are the most consistently associated risk factors for MDS and/or AML. Radiation has been linked with CML, and cigarette smoking with AML. Fewer risk factors have been identified for MPNs. Some evidence implicates increased risks of AML in rubber workers, farmers, and other agricultural workers.
Gli stili APA, Harvard, Vancouver, ISO e altri
37

1951-, Pui Ching-Hon, a cura di. Treatment of acute leukemias: New directions for clinical research. Totowa, N.J: Humana Press, 2003.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
38

Pui, Ching-Hon. Treatment of Acute Leukemias: New Directions for Clinical Research (Current Clinical Oncology). Humana Press, 2003.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
39

Vehling-Kaiser, Ulla, e Marcel U. Heim. The Leukemia Patient As Partner in Therapy: A Guidebook for Patients, Relatives, Nurses and Physicians (Supportive Measures in Oncology/Import). Thieme Medical Pub, 1994.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
40

Fridbinstons, Pit Alex. Causes of Thrombocytopenia: Enlarged Spleen, Anemia, Leukemia, Pregnancy, Heavy Alcohol Consumption, Viral Infections, Chemotherapy Medications, Hemolytic Uremic Syndrome, Thrombotic Thrombocytopenic Purpura. Independently Published, 2021.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
41

Cheson. Nucleoside Analogs Cancer Therapy (Basic and Clinical Oncology, 12). Informa Healthcare, 1997.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
42

KAS, GERT-JAN L. Drug Resistance in Leukemia and Lymphoma: The Clinical Value of Laboratory Studies. Taylor & Francis, 1993.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
43

Plunkett, W., M. Keating, W. Hiddemann, T. Büchner e B. Wörmann. Acute Leukemias: Pharmacokinetics and Management of Relapsed and Refractory Disease. Springer London, Limited, 2012.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
44

Buchner, T., e W. Hiddemann. Acute Leukemias: Pharmacokinetics and Management of Relapsed and Refractory Disease (Haematologie Und Bluttransfusion). Springer-Verlag, 1992.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
45

Acute Leukaemias (Hamatologie und Bluttransfusion). Springer-Verlag Berlin and Heidelberg GmbH & Co. K, 1992.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
46

1926-, Cacciola E., Deisseroth Albert B. 1941- e Giustolisi R, a cura di. Hemopoietic growth factors, oncogenes, and cytokines in clinical hematology: Current aspects and future directions. Basel: Karger, 1994.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
47

Negative regulators of hematopoiesis: Studies on their nature, action, and potential role in cancer therapy. New York, N.Y: New York Academy of Sciences, 1991.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
48

Najman, Albert, Athanasius Anagnostou e Nicholas Dainiak. Negative regulators of hematopoiesis : Studies on their nature, action, and potential role in cancer therapy. New York Academy of Sciences, 1991.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
49

Athanasius, Anagostou, Dainiak Nicholas, Najman Albert e International Conference on Negative Regulators of Hematopoiesis, (2nd : 1990 : Providence, R.I.), a cura di. Negative regulators of hematopoiesis: Studies of their nature, action, and potential role in cancer therapy. New York, N.Y: New York Academy of Sciences, 1991.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
50

Anagnostou, Athanasius, e Nicholas Dainiak. Negative Regulators of Hematopoiesis: Studies on Their Nature, Action, and Potential Role in Cancer Therapy (Annals of the New York Academy of Scien). New York Academy of Sciences, 1991.

Cerca il testo completo
Gli stili APA, Harvard, Vancouver, ISO e altri
Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!

Vai alla bibliografia